EU votes for tighter internet drug regulations
May 4, 2010Sales and Marketing EU, counterfeits, viagra
The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …
Staff cuts already planned, warns nurses’ leader
May 4, 2010NHS trusts, election, general election, nurses
The leader of nurses in the UK has warned that NHS trusts around the country are already planning significant job …
Contract research news in brief
May 4, 2010Research and Development Corealis, Norwich Pharma, PPD, PRA, biofocus
Our round-up of developments in the contract research sector includes a new $41m contract for BioFocus, new locations for PPD, …
Evotec wins grant to advance H3 receptor antagonist
May 4, 2010Research and Development CNS, Evotec, MS
Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …
Digital Pharma: Bayer expands InBed ED campaign
April 30, 2010Medical Communications Bayer Schering Pharma, digital pharma, disease awareness campaigns, erectile dysfunction
Bayer Schering Pharma has launched a Spanish version of its InBed erectile dysfunction disease awareness campaign. Under the tagline ‘en la …
Colorcon buys French excipients specialist
April 30, 2010Manufacturing and Production Colorcon, Ethypharm, NP Pharm, contract manufacturing, excipients
US-based Colorcon has acquired excipient specialist NP Pharm, a division of French drugmaker Ethypharm, in order to expand its product portfolio …
Shire revenue dips after generic Adderall hit
April 30, 2010Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire
Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva. This …
FDA warns Teva over California plant
April 30, 2010Manufacturing and Production Teva, manufacturing compliance
Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …
Plavix boosts BMS first quarter figures
April 30, 2010Sales and Marketing BMS, Plavix
Plavix has boosted Bristol-Myers Squibb’s performance in the first quarter of the year, with sales of the anti-clotting blockbuster up …
Merck separates president role, appoints Kenneth Frazier
April 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing
Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
Victoza claims head-to-head victory over Januvia
April 29, 2010Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza
Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …
Investors get green light to continue Merck lawsuit
April 29, 2010Merck, Vioxx
Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …
CME Spotlight: De-coding the letter of the law
April 29, 2010Medical Communications CME, CME Spotlight
Legal systems can raise interesting philosophical points sometimes.At the time of writing, the UK is in the throws of a …
Doctors.net.uk reports record year for online interaction with doctors
April 29, 2010Medical Communications CME, doctors.net, social networking
Online doctors’ community Doctors.net.uk says it saw record levels of doctor engagement in 2009, with 25 million unique web sessions during …
US pharma execs join Algeta board
April 29, 2010Research and Development Algeta, appointment, research and development
Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …
RNA Interference using nanoparticles hits target in human patients
April 29, 2010Research and Development SiRNA, nanoparticles, rnai
US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …
Asia and emerging markets boost GSK results
April 28, 2010Sales and Marketing GSK
Asia and emerging markets boost GlaxoSmithKline results GlaxoSmithKline has seen a jump in pharma sales due to major growth in …
Merck bounces back
April 28, 2010Sales and Marketing Merck KGaA
Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …
Obituary – Tony Forbes-Leith
April 28, 2010Business Services appointment, business services, rsa
RSA director Tony Forbes-Leith passed away last month after a long and serious illness. He officially joined the company in …
AstraZeneca settles Seroquel marketing charges
April 28, 2010Sales and Marketing Seroquel
AstraZeneca has agreed to pay $520 million to settle US federal investigations into the marketing of its antipsychotic blockbuster Seroquel. …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
